일차의료 한의 방문진료 수가 시범사업 효과평가 및 개선 방안
- Table Of Contents
- 요약 ···························································································· ⅰ
제1장 서론 1
1. 연구배경 ······························································································ 3
2. 연구 목적 ······························································································ 4
3. 연구 내용 및 방법 ·················································································· 5
제2장 국내외 방문진료 제도 현황 7
1. 국내 방문진료 제도 현황 ······································································· 9
2. 국외 방문진료 제도 현황 ······································································· 19
제3장 일차의료 한의 방문진료 수가 시범사업 현황 31
1. 분석개요 ······························································································ 33
2. 일반 현황 ···························································································· 33
제4장 일차의료 한의 방문진료 수가 시범사업 효과평가 49
1. 효과평가 틀 ························································································· 51
2. 의료접근성 ··························································································· 53
3. 한의 방문진료 이용 전후 의료이용량 변화 ·············································· 53
4. 환자·한의사 대상 시범사업 참여경험 및 만족도 조사 ································ 55
제5장 일차의료 한의 방문진료 수가 시범사업 개선방안 65
1. 수가 개선(안) ······················································································· 67
2. 기준 개선(안) ······················································································· 68
3. 점검서식 개선(안) ················································································· 69
제6장 결론 및 제언 71
◾ 참고 문헌 ····················································································· 77
◾ 부록 ····························································································· 79
- Publisher
- 건강보험심사평가원
- Location
- KOR
- Citation
- 위세아. (2024-12). 일차의료 한의 방문진료 수가 시범사업 효과평가 및 개선 방안.
-
Appears in Collections:
- HIRA 연구 > 1. 자체연구
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.